Dr. Coral Omene, MD, PhD
Claim this profileRutgers Cancer Institute of New Jersey
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
24 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
Stage II
2Breast Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Coral Omene, MD, PhD is currently running
Tirzepatide
for Weight Loss in Breast Cancer
This clinical trial aims to evaluate the effectiveness of tirzepatide in achieving a 5% or more body weight reduction in patients undergoing adjuvant treatment for hormone receptor-positive, HER2-negative (HR+/Her2-) breast cancer. The study will also assess the safety and tolerability of tirzepatide, its feasibility based on discontinuation rates, and completion of treatment. Secondary objectives include evaluating 3-year invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS), changes in BMI and body fat distribution, metabolic markers, and circulating tumor DNA (ctDNA).
Recruiting1 award Phase 27 criteria
Statins
for Breast Cancer
This study proposes that the addition of statins reduces the treatment delays or early discontinuations secondary to cardiotoxicity in patients with Stage I-III HER2 positive breast being treated with anti-HER2 therapy.
Recruiting1 award Phase 214 criteria
More about Coral Omene, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Coral Omene, MD, PhD has experience with
- Paclitaxel
- Tirzepatide
- U-13C-glucose
- Lipitor 40mg Tablet
- Lipitor 40Mg Tablet
- Anastrozole
Breakdown of trials Coral Omene, MD, PhD has run
Breast Cancer
Breast cancer
Severe Weight Loss
Cardiotoxicity
Cardiac Toxicity
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Coral Omene, MD, PhD specialize in?
Coral Omene, MD, PhD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Coral Omene, MD, PhD currently recruiting for clinical trials?
Yes, Coral Omene, MD, PhD is currently recruiting for 7 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Coral Omene, MD, PhD has studied deeply?
Yes, Coral Omene, MD, PhD has studied treatments such as Paclitaxel, Tirzepatide, U-13C-glucose.
What is the best way to schedule an appointment with Coral Omene, MD, PhD?
Apply for one of the trials that Coral Omene, MD, PhD is conducting.
What is the office address of Coral Omene, MD, PhD?
The office of Coral Omene, MD, PhD is located at: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903 United States. This is the address for their practice at the Rutgers Cancer Institute of New Jersey.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.